Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study.
Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study.
复制标题
DOI:
10.1097/ccm.0b013e3182741a54
复制
发表时间:
2013-03
影响因子:
8.8
通讯作者:
Ware LB
中科院分区:
文献类型:
--
作者:
Janz DR;Bastarache JA;Peterson JF;Sills G;Wickersham N;May AK;Roberts LJ 2nd;Ware LB
To determine the association of circulating cell-free hemoglobin with poor clinical outcomes in patients with sepsis and to characterize the potential protective effects of acetaminophen, an inhibitor of hemoprotein-mediated oxidation. Retrospective observational study. A total of 391 critically ill patients with sepsis in multiple intensive care units in an academic tertiary care hospital. None. Nonsurvivors had significantly higher plasma cell-free hemoglobin concentrations (median 20 mg/dl, IQR 10–40) measured on enrollment compared to survivors (10 mg/dl, IQR 10–30, p = 0.002). After controlling for potential confounders, patients with higher cell-free hemoglobin concentrations were significantly more likely to die in the hospital (OR 1.078, 95% CI 1.012–1.149, p = 0.02). In addition, receiving acetaminophen in the setting of increased cell-free hemoglobin was independently associated with a protective effect against death (OR 0.48, 95% CI 0.25–0.91, p = 0.026) and lower plasma concentrations of the lipid peroxidation product F2-isoprostanes (18.5 pg/ml IQR 9–22.2) compared to no acetaminophen (42 pg/ml, IQR 29.7–86, p = 0.009). In critically ill patients with sepsis, elevated concentrations of circulating cell-free hemoglobin are independently associated with an increased risk of death. Acetaminophen may exert a protective effect by reducing cell-free hemoglobin-induced induced oxidative injury.